Scientists are making significant breakthroughs in understanding the coronavirus and have completed development of a vaccine.

‘According to the media report, from last four years, the research of Katz’s team had been focused on developing a vaccine that could be customized to various viruses. It was piloting it with Infectious Bronchitis Virus, but as coronavirus swept China, started adapting the vaccine for COVID-19.’

“By the time the protein is ready, we hope to have found the right partner who can take us through the clinical stage. The clinical testing experiments themselves are not so long, and we can complete them in 30 days, plus another 30 days for human trials. Most of the time is bureaucracy – regulation and paperwork,” Chen Katz, Biotechnology Group Leader at the institute, was quoted as saying by The Times of Israel. 




Katz also said that the new oral vaccine for adults and children could ‘turn this disease into a very mild cold.’
He said that for many people who are inoculated and then infected by COVID-19, ‘potentially it will not affect them at all.’
The rapid potential progress by the state-funded Migal Galilee Research Institute stems from the fact that the institute has been working for four years toward a vaccine that could be customized for various viruses, and has now adapted that work to focus on the coronavirus, Katz said.
Katz’s group at Israel’s state-funded Migal Institute has become a source of hope to many around the world.
Advertisement
Source-IANS